| Lack of efficacy of the selective iNOS inhibitor GW274150 in prophylaxis of migraine headache HO Høivik, BE Laurijssens, LO Harnisch, CK Twomey, RM Dixon, ... Cephalalgia 30 (12), 1458-1467, 2010 | 90 | 2010 |
| Does the unfavorable pharmacokinetic and pharmacodynamic profile of the iNOS inhibitor GW273629 lead to inefficacy in acute migraine? BJ Van der Schueren, MW Lunnon, BE Laurijssens, F Guillard, J Palmer, ... The Journal of Clinical Pharmacology 49 (3), 281-290, 2009 | 46 | 2009 |
| Neuroprotection as initial therapy in acute stroke C Cantú, J Villarreal, JL Soto, F Barinagarrementeria, BGH Schoser, ... Cerebrovascular Diseases 8 (1), 59-72, 1998 | 41 | 1998 |
| Safety and tolerability of 619C89 after acute stroke KW Muir, SJC Hamilton, MW Lunnon, S Hobbiger, KR Lees Cerebrovascular Diseases 8 (1), 31-37, 1998 | 25 | 1998 |
| A Randomized, Double‐Blind, Placebo‐Controlled Ascending Dose Tolerance Study of 619C89 in Acute Stroke KW Muir, KR Lees, SJC Hamilton, CF George, SF Hobbiger, MW Lunnon Annals of the New York Academy of Sciences 765 (1), 328-329, 1995 | 24 | 1995 |
| Report on the Society of Pharmaceutical Medicine Working Party Meeting on pharmacogenetics held at the Royal Institution, London, 26 April 2001 MW Lunnon International Journal of Pharmaceutical Medicine 15 (4), 201-204, 2001 | 17 | 2001 |
| Pharmacokinetics of 619C89, a novel neuronal sodium channel inhibitor, in acute stroke patients after loading and discrete maintenance infusions Z Hussein, IJ Fraser, KR Lees, KW Muir, MW Lunnon, SF Hobbiger, ... British journal of clinical pharmacology 41 (6), 505-511, 1996 | 17 | 1996 |
| Does the Unfavorable Pharmacokinetic and Pharmacodynamic Profile of the iNOS Inhibitor GW273629 Lead to Inefficacy in Acute Migraine? BJ Schueren, MW Lunnon, BE Laurijssens, F Guillard, J Palmer, ... The Journal of Clinical Pharmacology 49 (3), 281-290, 2009 | 5 | 2009 |
| First Report of the Ethics Sub-Group F Wells, MW Lunnon, Pharmacogenetics Working Party International Journal of Pharmaceutical Medicine 14 (1), 58-58, 2000 | 5 | 2000 |
| Effect of changes in metabolic enzymes and transporters on drug metabolism in the context of liver disease: Impact on pharmacokinetics and drug–drug interactions S Armani, A Geier, T Forst, U Merle, DH Alpers, MW Lunnon British Journal of Clinical Pharmacology 90 (4), 942-958, 2024 | 4 | 2024 |
| iNOS inhibition in acute migraine: pharmacokinetic characteristics, safety and tolerability of GW273629 B Van Der Schueren, MW Lunnon, B Laurijssens, F Guillard, J Palmer, ... Cephalalgia 27 (6), 721-722, 2007 | 3 | 2007 |
| The current status of antihypertensive treatments: into the new millennium TC Hardman, MW Lunnon Expert Opinion on Pharmacotherapy 2 (5), 731-737, 2001 | 3 | 2001 |
| The impact of molecular medicine upon early cardiovascular drug development MW Lunnon, M Braddock British journal of clinical pharmacology 50 (1), 1, 2000 | 3 | 2000 |
| A Randomised, Double-Blind, Placebo Controlled Study in Healthy Male Subjects to Assess the Effect of Subanaesthetic Intravenous Doses of Ketamine upon Neurocognitive Functions. MW Lunnon, C Audebert, C Casse-Perrot, J Micallef, S He, J Pinquier, ... CLINICAL PHARMACOLOGY & THERAPEUTICS 89, S69-S69, 2011 | 2 | 2011 |
| Making progress in the acute treatment of stroke: preclinical and clinical challenges for pharmaceutical medicine MF James, MW Lunnon International journal of pharmaceutical medicine 19, 77-88, 2005 | 2 | 2005 |
| Pharmacogenetics Working Party: introduction ST Holgate, MW Lunnon International Journal of Pharmaceutical Medicine 15 (2), 63-65, 2001 | 2 | 2001 |
| Prolonged pharmacodynamic effects of S‐0139, an intravenously administered endothelin A (ETA) antagonist, in the human forearm blood flow model MW Lunnon, SML Wallace, JE Palmer, A Francis‐Lang, BE Laurijssens, ... British journal of clinical pharmacology 69 (3), 252-261, 2010 | 1 | 2010 |
| Dose-related effects of subanesthetic intravenous ketamine upon neurocognitive functions in healthy subjects J Micallef-Roll, C Audebert, C Casse-Perrot, F Rouby, M Lunnon, S He, ... FUNDAMENTAL & CLINICAL PHARMACOLOGY 23, 104-104, 2009 | | 2009 |
| SOCiETY oF PHARMACEUTiCAL MEdiCiNE. MW Lunnon Pharmaceutical Medicine 22 (3), 2008 | | 2008 |
| Society of Pharmaceutical Medicine MW Lunnon, T Fox International Journal of Pharmaceutical Medicine 20 (4), 283-285, 2006 | | 2006 |
